Cargando…
Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines?
Coronavirus disease 2019 (COVID-19) vaccines have shown excellent clinical efficacy and effectiveness in real-world data. Although they are regarded as a means of ending the global pandemic, some individuals become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after immu...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731259/ https://www.ncbi.nlm.nih.gov/pubmed/34979603 http://dx.doi.org/10.3947/ic.2021.0134 |
_version_ | 1784627320080826368 |
---|---|
author | Lamptey, Emmanuel |
author_facet | Lamptey, Emmanuel |
author_sort | Lamptey, Emmanuel |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) vaccines have shown excellent clinical efficacy and effectiveness in real-world data. Although they are regarded as a means of ending the global pandemic, some individuals become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after immunization. This growing evidence or lack of effectiveness has led to vaccine refusal. This paper sought to help the public gain a deeper understanding of breakthrough events creating the positive perception that vaccines remain effective in ending the pandemic. Discussions vital for the general public’s active participation in vaccination are expressed to create confidence or provide a potential solution to the challenge of vaccine hesitancy. |
format | Online Article Text |
id | pubmed-8731259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS |
record_format | MEDLINE/PubMed |
spelling | pubmed-87312592022-01-13 Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines? Lamptey, Emmanuel Infect Chemother Review Article Coronavirus disease 2019 (COVID-19) vaccines have shown excellent clinical efficacy and effectiveness in real-world data. Although they are regarded as a means of ending the global pandemic, some individuals become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after immunization. This growing evidence or lack of effectiveness has led to vaccine refusal. This paper sought to help the public gain a deeper understanding of breakthrough events creating the positive perception that vaccines remain effective in ending the pandemic. Discussions vital for the general public’s active participation in vaccination are expressed to create confidence or provide a potential solution to the challenge of vaccine hesitancy. The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021-12 2021-12-24 /pmc/articles/PMC8731259/ /pubmed/34979603 http://dx.doi.org/10.3947/ic.2021.0134 Text en Copyright © 2021 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Lamptey, Emmanuel Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines? |
title | Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines? |
title_full | Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines? |
title_fullStr | Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines? |
title_full_unstemmed | Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines? |
title_short | Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines? |
title_sort | should breakthrough sars-cov-2 infection affect our confidence in the covid-19 vaccines? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731259/ https://www.ncbi.nlm.nih.gov/pubmed/34979603 http://dx.doi.org/10.3947/ic.2021.0134 |
work_keys_str_mv | AT lampteyemmanuel shouldbreakthroughsarscov2infectionaffectourconfidenceinthecovid19vaccines |